Search

Search bills, members, committees and pages...

H.R. 1878

U.S. HouseIn House Committee

Summary

H.R. 1878, the IVF Access and Affordability Act, was introduced in the House on Mar 5, 2025 by Rep. Michael Lawler (R) with 3 co-sponsors. It was referred to Ways And Means, and last saw action on Mar 5, 2025: Referred to the House Committee on Ways and Means.


Record

Text

H.R. 1878 has 3 co-sponsors.

hb1878/introduced-in-house.txt
119 HR 1878 IH: IVF Access and Affordability Act
U.S. House of Representatives
2025-03-05
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
I 119th CONGRESS 1st Session H. R. 1878 IN THE HOUSE OF REPRESENTATIVES March 5, 2025 Mr. Lawler (for himself, Mr. Wittman , and Mrs. Luna ) introduced the following bill; which was referred to the Committee on Ways and Means A BILL
To amend the Internal Revenue Code of 1986 to provide an income tax credit for fertility treatments.
1.
Short title
This Act may be cited as the IVF Access and Affordability Act .
2.
Credit for fertility treatments
(a)
In general
Subpart A of part IV of subchapter A of chapter 1 of the Internal Revenue Code of 1986 is amended by inserting before section 24 the following new section:
23A.
Credit for fertility treatments
(a)
Allowance of credit
In the case of an eligible individual, there shall be allowed as a credit against the tax imposed by this chapter for the taxable year an amount equal to the assisted reproductive technology expenses paid or incurred during the taxable year.
(b)
Limitations
(1)
Dollar limitation
(A)
In general
The amount of the credit under subsection (a) for any taxable year shall not exceed $20,000.
(B)
Special rule
In the case of two individuals filing a joint return or an individual filing as a surviving spouse (as defined in section 2(a)) with respect to a taxable year in which both individuals, or the individual and the spouse of such individual, incur assisted reproductive technology expenses, subparagraph (A) shall be applied by substituting $40,000 for $20,000 .
(2)
Income limitation
(A)
In general
The amount otherwise allowable as a credit under subsection (a) for any taxable year shall be reduced (but not below zero) by an amount which bears the same ratio to the amount so allowable as—
(i)
the amount (if any) by which the taxpayer’s adjusted gross income exceeds $200,000, bears to
(ii)
$100,000.
(B)
Special rule
In the case of a joint return or a surviving spouse (as defined in section 2(a)), subparagraph (A) shall be applied by substituting $400,000 for $200,000 and $200,000 for $100,000 .
(C)
Determination of adjusted gross income
For purposes of subparagraph (A), adjusted gross income shall be determined without regard to sections 911, 931, and 933.
(3)
Denial of double benefit
(A)
In general
Any assisted reproductive technology expense taken into account for purposes of any deduction (or any credit other than the credit allowed under this section) shall be reduced by the amount of the credit allowed under subsection (a) with respect to such expense.
(B)
Reimbursement
No credit shall be allowed under subsection (a) for any expense to the extent that payment for such expense is made, or reimbursement for such expense is received, under any insurance policy or otherwise.
(c)
Carryforwards of unused credit
(1)
In general
If the credit allowable under subsection (a) exceeds the limitation imposed by section 26(a) for such taxable year reduced by the sum of the credits allowable under this subpart (other than this section and section 25D), such excess shall be carried to the succeeding taxable year and added to the credit allowable under subsection (a) for such succeeding taxable year.
(2)
Limitation
No credit may be carried forward under this subsection to any taxable year after the 5th taxable year after the taxable year in which the credit arose. For purposes of the preceding sentence, credits shall be treated as used on a first-in, first-out basis.
(d)
Assisted reproductive technology
For purposes of this section, the term assisted reproductive technology has the meaning given such term in section 8 of the Fertility Clinic Success Rate and Certification Act of 1992 ( 42 U.S.C. 263a–7 ).
(e)
Eligible individual
For purposes of this section, the term eligible individual means the taxpayer, the spouse of the taxpayer, or a dependent of the taxpayer.
(f)
Special rules
(1)
Married couples must file joint returns
Rules similar to the rules of paragraphs (2), (3), and (4) of section 21(e) shall apply for purposes of this section.
(2)
Denial of double benefit for dependents
No credit shall be allowed under this section to a taxpayer who is a dependent (as defined in section 152(a)) for assisted reproductive technology expenses for which a credit has been claimed by another taxpayer under this section.
.
(b)
Conforming amendments
(1)
The table of sections for subpart A of part IV of subchapter A of chapter 1 of the Internal Revenue Code of 1986 is amended by inserting after the item relating to section 23 the following new item:
Sec. 23A. Credit for fertility treatments.
.
(2)
Section 23(c)(1) of such Code is amended by striking section 25D and inserting sections 23A and 25D .
(3)
Section 25(e)(1)(C) of such Code is amended by inserting , 23A, after 23 .
(c)
Effective date
The amendments made by this section shall apply to taxable years beginning after the date of the enactment of this Act.

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

  1. Introduced2025-03-05
  2. Passed House
  3. Passed Senate
  4. Conference
  5. To President
  6. Became Law

To amend the Internal Revenue Code of 1986 to provide an income tax credit for fertility treatments.

Sponsors

Rep. Michael Lawler (R) sponsors H.R. 1878, and 3 members have co-sponsored it, 2 of them from the day it was introduced.

Committees

H.R. 1878 went before 1 committee: Ways and Means.

Ways and Means
Ways and Means
Referred To · Mar 5, 2025 · 1,160 Bills

Actions

H.R. 1878 has taken 2 actions since Mar 5, 2025.

ChamberAction
Mar 5, 2025
House
Introduced in House
Mar 5, 2025
House
Referred to the House Committee on Ways and Means.Ways and Means Committee

Votes

H.R. 1878 has not gone to a roll call.

Titles

H.R. 1878 goes by 3 titles, 1 of them short titles.

  • To amend the Internal Revenue Code of 1986 to provide an income tax credit for fertility treatments. — Official Title as Introduced
  • IVF Access and Affordability Act — Display Title
  • IVF Access and Affordability Act — Short Title(s) as Introduced

Lobbying

2 clients hired 2 firms and 5 registered lobbyists who named H.R. 1878 in 12 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Health Issues, Civil Rights/Civil Liberties, Education, Family issues/Abortion/Adoption, Foreign Relations, Medical/Disease Research/Clinical Labs, Taxation/Internal Revenue Code, Budget/Appropriations.

Clients

Who paid to be heard, by how many filings named the bill.

ClientBusinessStateFirmsFilingsReported
FERRING PHARMACEUTICALS, INC.District of Columbia16
HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.New York16

Firms

Registrants who filed on the bill, by filings.

Lobbyists

Named on the filings that cite the bill.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

ClientRegistrantPeriodReportedDocument
FERRING PHARMACEUTICALS, INC.FERRING PHARMACEUTICALS, INC.2025 fourth_quarter$290K4th Quarter - Report
FERRING PHARMACEUTICALS, INC.FERRING PHARMACEUTICALS, INC.2026 second_quarter$250K2nd Quarter - Report
FERRING PHARMACEUTICALS, INC.FERRING PHARMACEUTICALS, INC.2026 first_quarter$220K1st Quarter - Report
FERRING PHARMACEUTICALS, INC.FERRING PHARMACEUTICALS, INC.2025 third_quarter$160K3rd Quarter - Report
FERRING PHARMACEUTICALS, INC.FERRING PHARMACEUTICALS, INC.2025 second_quarter$160K2nd Quarter - Report
FERRING PHARMACEUTICALS, INC.FERRING PHARMACEUTICALS, INC.2025 first_quarter$160K1st Quarter - Report
HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.2026 second_quarter$60K2nd Quarter - Report
HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.2026 first_quarter$60K1st Quarter - Report
HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.2025 fourth_quarter$60K4th Quarter - Report
HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.2025 third_quarter$60K3rd Quarter - Report
HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.2025 second_quarter$60K2nd Quarter - Report
HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.2025 first_quarter$60K1st Quarter - Report

Classification

The Congressional Research Service files H.R. 1878 under Taxation, one of its 31 policy areas.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 1878’s is Taxation.

hr1878/policy-areas.txt
TaxationAgriculture and FoodAnimalsArmed Forces and National SecurityArts, Culture, ReligionCivil Rights and Liberties, Minority IssuesCommerceCongressCrime and Law EnforcementEconomics and Public FinanceEducationEmergency ManagementEnergyEnvironmental ProtectionFamiliesFinance and Financial SectorForeign Trade and International FinanceGovernment Operations and PoliticsHealthHousing and Community DevelopmentImmigrationInternational AffairsLabor and EmploymentLawNative AmericansPublic Lands and Natural ResourcesScience, Technology, CommunicationsSocial WelfareSports and RecreationTransportation and Public WorksWater Resources Development

Source: congress.gov · legiscan.com